Mgr. Karla Plevová, Ph.D.
Head of the research group, Karla Plevová Research Group: Genomics of Immune Cells
correspondence Address:
Jihlavská 340/20, 625 00 Brno
office: bldg. E35/258
Kamenice 753/5
625 00 Brno
phone: | +420 532 23 4396 |
---|---|
e‑mail: | |
web: | https://genomika.med.muni.cz/research/research-groups/karla-plevova-group/about-us |
social and academic networks: |
---|
Total number of publications: 359
2021
-
Exploring clonal evolution and genetic causes of therapy failure in chronic lymphocytic leukemia.
Year: 2021, type: Conference abstract
-
Exploring transposone activity in hematological malignances.
Year: 2021, type: Conference abstract
-
Fosforylace proteinu p53: vliv na aktivitu dráhy p53 po poškození DNA u chronické lymfocytární leukémie.
Year: 2021, type: Conference abstract
-
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study
Haematologica, year: 2021, volume: 106, edition: 1, DOI
-
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
Blood, year: 2021, volume: 137, edition: 10, DOI
-
Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169
Blood, year: 2021, volume: 137, edition: 14, DOI
-
Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability
Frontiers in Oncology, year: 2021, volume: 11, edition: November 2021, DOI
-
Identification of Clinically Relevant Subgroups of Chronic Lymphocytic Leukemia Through Discovery of Abnormal Molecular Pathways
Frontiers in Genetics, year: 2021, volume: 12, edition: JUN, DOI
-
Klinický dopad a evoluce minoritních TP53-mutovaných klonů v kontextu různých terapeutických režimů u CLL.
Year: 2021, type: Conference abstract
-
Klonální evoluce CLL – význam BCR receptoru a abnormalit genu TP53.
Year: 2021, type: Conference abstract